Use of doxorubicin is not associated with hemolytic complications in severely G6PD deficient patients with lymphoma. Prem Sudha S, Shehata A, Al-Ali F, Abdelfattah N, et al. Leuk Lymphoma 2025 Jun 24:1-7. doi: 10.1080/10428194.2025.2521654.

Read + Share

Amedeo Smart

Independent Medical Education

Prem Sudha S, Shehata A, Al-Ali F, Abdelfattah N, et al. Use of doxorubicin is not associated with hemolytic complications in severely G6PD deficient patients with lymphoma. Leuk Lymphoma 2025 Jun 24:1-7. doi: 10.1080/10428194.2025.2521654.
PMID: 40554567